Article

P300 latency reflects the degree of cognitive decline in dementing illness

Department of Psychiatry, University of California, San Diego, La Jolla, CA 92093 U.S.A.
Electroencephalography and Clinical Neurophysiology 03/1986; 63(2):138-144. DOI: 10.1016/0013-4694(86)90007-6

ABSTRACT An auditory discrimination paradigm was employed to elicit the P3 component of the event-related brain potential (ERP) from 39 demented patients (mean age = 71 years). Component latency was longer in patients who were diagnosed as having primary degenerative dementia and other cognitive impairment disorders compared to age-matched controls. Neurologist ratings of cognitive impairment were significantly correlated with P3 latency values, although no differences in mean latency were obtained between the various categories of dementia. ERP measurement techniques and the interpretation of P3 latency as an index of dementing illness are discussed.

0 Bookmarks
 · 
63 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: MMN and P300 present smaller amplitude and longer latencies with age.•Brain source localization of P300 and maximum current field intensity shift significantly with age.•Brain source localization of ERP components is gender related, with more pronounced differences in younger age.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To objectively assess the clinical effects of nicergo-line on demented patients, we recorded the P300 component of event-related potentials (ERPs) during an oddball paradigm before and after the administration of nicergoline in 17 patients with multi-infarct dementia. The patients received nicergoline (15 mg/day) for four weeks. ERPs were derived from the Fz, Cz, and Pz regions. Infrequent target tones elicited P300 components. After the administration of nicergoline, P300 amplitude increased and P300 latency decreased significantly, which indicated improved cognitive function in the patients. The results in this study suggest that the P300 component is a sensitive index for the effects of cerebral-metabolic enhancers.
  • [Show abstract] [Hide abstract]
    ABSTRACT: P300 (P3) event-related potentials (ERPs) have been suggested to be an endogenous marker of cognitive function and auditory oddball paradigms are frequently used to evaluate P3 ERPs in clinical settings. Deficits in P3 amplitude and latency reflect some of the neurological dysfunctions related to several psychiatric and neurological diseases, e.g., Alzheimer's disease (AD). However, only a very limited number of rodent studies have addressed the back-translational validity of the P3-like ERPs as suitable markers of cognition. Thus, the potential of rodent P3-like ERPs to predict pro-cognitive effects in humans remains to be fully validated. The current study characterizes P3-like ERPs in the 192-IgG-SAP (SAP) rat model of the cholinergic degeneration associated with AD. Following training in a combined auditory oddball and lever-press setup, rats were subjected to bilateral intracerebroventricular infusion of 1.25 μg SAP or PBS (sham lesion) and recording electrodes were implanted in hippocampal CA1. Relative to sham-lesioned rats, SAP-lesioned rats had significantly reduced amplitude of P3-like ERPs. P3 amplitude was significantly increased in SAP-treated rats following pre-treatment with 1 mg/kg donepezil. Infusion of SAP reduced the hippocampal choline acetyltransferase activity by 75%. Behaviorally defined cognitive performance was comparable between treatment groups. The present study suggests that AD-like deficits in P3-like ERPs may be mimicked by the basal forebrain cholinergic degeneration induced by SAP. SAP-lesioned rats may constitute a suitable model to test the efficacy of pro-cognitive substances in an applied experimental setup.
    Journal of Alzheimer's disease: JAD 07/2014; 42(4). DOI:10.3233/JAD-131502 · 3.61 Impact Factor